November 7, 2016
Richard Jones goes from Shield Therapeutics to Mereo as CFO
Mereo BioPharma has appointed Richard CM Jones as Chief Financial Officer
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
November 7, 2016
Celyad's NKR phase I trial shows encouraging results
The first data analysis of the NKR-2 Phase I trial, run by the Belgia’s biopharmaceutical company Celyad, shows encouraging results
November 7, 2016
Avacta names Prof. Gerard Evans to its Scientific Advisory Board
Professor Gerard Evan, FRS, has joined Scientific Advisory Board of Avacta Group, the developer of Affimer biotherapeutics and research reagents.
November 4, 2016
Genfit gets FDA’s IND clearance for PBC drug to go on with phase 2 study
The primary objective is to determine the effect of daily oral administration of elafibranor on serum alkaline phosphatase (ALP) in these patients, based on relative change versus placebo.
November 4, 2016
Cardinal Health approves a regular quarterly dividend
Cardinal Health has announced on Thursday that the board of directors approved a regular quarterly dividend…
November 3, 2016
LeoPharma and Morphosys join forces to fight skin diseases
LEO Pharma and MorphoSys AG have entered into a strategic alliance for the discovery and development of therapeutic antibodies for the treatment…
November 3, 2016
Positive outcome of Mereo’s phase 1 study of acute exacerbations of COPD drug
Mereo reports positive outcome of its phase 1 study of acute exacerbations of COPD drug
November 2, 2016
GE Healthcare, Valneva join forces to create cell culture medium for vaccine
GE Healthcare and Valneva have joined forces to create cell culture medium for vaccine
November 2, 2016
Targovax CEO steps down, current CFO takes the role
Targovax CEO has stepped down, current CFO takes the role
November 2, 2016
European Patent Office OKs new patent for Allergy Therapeutics’ Microcrystalline Tyrosine tech
European Patent Office OKs new patent for Allergy Therapeutics’ Microcrystalline Tyrosine tech